elranatamab will boost the degree or outcome of fentanyl transdermal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Elranatamab causes cytokine launch syndrome (CRS) which will suppress activity of CYP enzymes, resulting in amplified publicity of CYP substrates.Fentanyl can cause really serious undesired results or m